AD04

· ADvantage Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AD04, covering 2024-04-17 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Effects of a Widely Used Vaccine Adjuvant in Subjects With Early Alzheimer's Disease Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE [Phase 2]

See pricing